Cancer-derived exosomes as a delivery platform of CRISPR/Cas9 confer cancer cell tropism-dependent targeting
- Authors
- Kim, Seung Min; Yang, Yoosoo; Oh, Seung Ja; Hong, Yeonsun; Seo, Minkoo; Jang, Mihue
- Issue Date
- 2017-11-28
- Publisher
- ELSEVIER SCIENCE BV
- Citation
- JOURNAL OF CONTROLLED RELEASE, v.266, pp.8 - 16
- Abstract
- An intracellular delivery system for CRISPR/Cas9 is crucial for its application as a therapeutic genome editing technology in a broad range of diseases. Current vehicles carrying CRISPR/Cas9 limit in vivo delivery because of low tolerance and immunogenicity; thus, the in vivo delivery of genome editing remains challenging. Here, we report that cancer-derived exosomes function as natural carriers that can efficiently deliver CRISPR/Cas9 plasmids to cancer. Compared to epithelial cell-derived exosomes, cancer-derived exosomes provide potential vehicles for effective in vivo delivery via selective accumulation in ovarian cancer tumors of SKOV3 xenograft mice, most likely because of their cell tropism. CRISPR/Cas9-loaded exosomes can suppress expression of poly (ADP-ribose) polymerase-1 (PARP-1), resulting in the induction of apoptosis in ovarian cancer. Furthermore, the inhibition of PARP-1 by CRISPR/Cas9-mediated genome editing enhances the chemosensitivity to cisplatin, showing synergistic cytotoxicity. Based on these results, tumor-derived exosomes may be very promising for cancer therapeutics in the future.
- Keywords
- EXTRACELLULAR VESICLES; OVARIAN-CANCER; COMMUNICATORS; NANOCARRIERS; RESISTANCE; VEHICLES; IMMUNITY; SIRNA; PARP; EXTRACELLULAR VESICLES; OVARIAN-CANCER; COMMUNICATORS; NANOCARRIERS; RESISTANCE; VEHICLES; IMMUNITY; SIRNA; PARP; CRISPR/Cas9; Gene editing; Cancer therapy, combination therapy; Delivery vehicle; Exosomes; PARP-1; Cisplatin
- ISSN
- 0168-3659
- URI
- https://pubs.kist.re.kr/handle/201004/122037
- DOI
- 10.1016/j.jconrel.2017.09.013
- Appears in Collections:
- KIST Article > 2017
- Files in This Item:
There are no files associated with this item.
- Export
- RIS (EndNote)
- XLS (Excel)
- XML
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.